Dapagliflozin: a sodium–glucose cotransporter 2 inhibitor, attenuates angiotensin II-induced cardiac fibrotic remodeling by regulating TGFβ1/Smad signaling

Yuze Zhang(Fujian Medical University), Dajun Chai(Fujian Medical University)
Cardiovascular Diabetology
June 11, 2021
Cited by 98


Related Papers